ArticleFrontiers in oncology2026
Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors.
Antoine Italiano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it